3 Results for "

NOR paradigm

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "NOR paradigm" in MCE Product Catalog:

Cat. No.: HY-179004
CAS No.: 2640753-22-4
Synonyms: VU6022856
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

ONO-9517601 is a potent, orally active, selective and CNS penetrant dual TREK-1/TREK-2 inhibitor (TREK-1 IC50= 0.067 μM, TREK-2 IC50= 0.23 μM). ONO-9517601 displays robust efficacy in an MK-801 (HY-15084B) challenge rat novel object recognition (NOR) paradigm. ONO-9517601 can be used for research on neurological and cognitive disorders .
loading...
    loading...
Cat. No.: HY-179005
CAS No.: 2640753-27-9
Synonyms: VU6024391
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

ONO-7927846 is a potent, orally active, selective and CNS penetrant dual TREK-1/TREK-2 inhibitor (TREK-1 IC50= 0.11 μM, TREK-2 IC50= 0.29 μM). ONO-7927846 displays robust efficacy in an MK-801 (HY-15084B) challenge rat novel object recognition (NOR) paradigm. ONO-7927846 can be used for research on neurological and cognitive disorders .
loading...
    loading...
Cat. No.: HY-184475
Synonyms: BI03738809
Target:  

mGluR

Research Areas:  

Neurological Disease

VU6053371 (BI03738809) is a first-in-class (FIC), selective, orally active, and brain-penetrant metabotropic glutamate receptor subtype 3 (mGlu3) positive allosteric modulator (PAM) with EC50s of 103 nM and 112 nM for human and rat mGlu3. VU6053371 exhibits selectivity for mGlu3 over other mGlu receptor subtypes. VU6053371 exhibits pro-cognitive effects in mouse models. VU6053371 can be used in research schizophrenia, Alzheimer’ s disease and other forms of dementia and cognitive impairment .
loading...
    loading...